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Summary
Objective: To test the hypothesis that chondrocytes are more responsive to the chondroprotective agents, glucosamine (glcN) and
chondroitin sulfate (CS), under in vitro conditions simulating in vivo joint stress.
Design: Synthetic and anticatabolic activities of bovine articular cartilage were assayed using 35-sulfate labeling and assaying the specific
activity of glycosaminoglycans (GAGs) under the conditions of enzyme-induced matrix depletion, heat stress, mechanical compression and
cytokine stress.
Results: The response of cartilage to simulated conditions of in vivo stress varies, depending on the type stress and age of the animal.
Cartilage from aged animals was more responsive to stress and to glcN and CS. Pronase-induced matrix depletion and mechanical stress
increased proteoglycan synthetic activity. Exposure to glcN and CS significantly enhanced this stress response from 85 to 191% and from
40 to 1000%, respectively. Heat stress and stromelysin digestion decreased synthetic activity, which was reversed or normalized on
exposure to glcN and CS. Cartilage from young joints was somewhat refractory to the level of stress imposed and to treatment with glcN and
CS.
Conclusion: The metabolic response of cartilage from aged animals to glcN and CS under simulated conditions of in vivo stress is
significantly greater than that seen in nonstressed or young tissue. By enhancing the ‘protective’ metabolic response of chondrocytes to
stress, glcN and CS may improve its ability for repair and regeneration. These observations suggest that these compounds function as
biological response modifiers (BRMs), agents which boost natural protective responses of tissues under adverse environmental conditions.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Science Ltd. All rights reserved.
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Introduction
Osteoarthrosis (OA) is a multifactorial disorder of diarthro-
dial joints with aging, genetic and hormonal influences and
no evidence of a primary metabolic defect in cartilage1.
Exposure of articular cartilage to localized physical or
chemical stresses, including mechanical2,3, inflammatory4,
oxidative5,6, and thermal7 entities, may contribute to the
depletion of matrix macromolecules. In fact, the hyper-
metabolic state seen early in OA is considered a reactive
feedback response of chondrocytes to proteoglycan deple-
tion in the matrix. Under these circumstances, cartilage
lesions ultimately develop because the stress-induced
‘hypermetabolic’ response is dominated by a catabolic
cascade and degradation of cartilage matrix8. Degener-
ation of cartilage is progressive, facilitated by continual
excessive and/or aberrant stresses9,10.
If the ‘hypermetabolic’ response seen in early OA is a
protective, albeit ineffective, attempt to counteract the
results of environmental stress, agents, which enhance
the anabolic response and diminish the catabolic re-
sponse may retard the progression of cartilage degen-
eration. Natural agents endowed with this ability have
been termed biological response modifiers (BRM)11. The
term BRM originally referred to agents that enhance the
immuno-defensive response of hosts to pathogens or
cancer. BRM designation also refers to agents that affect
atherosclerosis12 and rheumatoid arthritis13, and include
naturally derived compounds like proteins14, polysac-
charides15 and glucans16. The definition implies that
these agents promote the defense of the host against
multiple stresses17. Our studies indicate that the
symptomatic/disease modifying osteoarthritis agents (S/
DMOADs) glucosamine (glcN) and chondroitin sulfate
(CS) are candidates for this classification. Indirect sup-
port for this concept is provided by several in vivo rabbit
studies. In one study, dietary supplements of glcN and
CS preserved cartilage matrix and slowed down the
progression of degenerative changes in a rabbit insta-
bility model of OA. In these animals, normal humeral
cartilage metabolism was not altered and the beneficial
response was attributed to their effect on chondrocytes
from the stressed joints9. In another study, glcN ad-
ministration to animals given intraarticular injections
of chymopapain improved proteoglycan content in
stressed cartilage, but had no effect on normal tissue18.
A related study indicated that CS administered to rabbits
prior to and following chymopapain injection had signifi-
cantly higher proteoglycan content in the injected
joint19.
To further explore the relationship between stress and
activities of glcN and CS, and to test the hypothesis that
these agents function by intensifying protective cellular
responses initiated by adverse environmental conditions, in
vitro simulations of in vivo joint stress were used.
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Materials and methods
Six millimeter diameter bovine cartilage explants from
normal radiocarpal joints of retired Holsteins (age 8–10
years) were conditioned to a metabolic steady state in
DMEM/F-12+12% fetal bovine serum and penicillin/
streptomycin for 6–10 days. In those experiments indi-
cated, tissue was also obtained from young (15 months old)
steers. When cell cultures were tested, cells isolated by
overnight digestion with 400 U/ml collagenase were
seeded at high density (60 000–80 000 cells/well) in
polylysine-coated 96 well micro plates. Total volume per
well was 250 µl and the media was changed daily. The cells
were utilized after culturing for 10 days. The dosage of
agents used in these studies was based on published data
indicating a 5–15% bioavailability of CS and evidence
of accumulation in tissues with continued dosing20,21. All
the agents were tested after dissolving in DMEM/F-12
containing 0.5% fetal bovine serum.
STRESS INDUCTION BY MATRIX DEPLETION
Conditions of matrix digestion sufficient to elicit a sub-
stantial reduction of matrix proteoglycans were established
using varying dosages of the proteolytic enzyme, pronase
(EC3.4.24.31, Sigma–Aldrich, St. Louis, MO). Stromelysin
(EC3.4.24.17) was used at much lower concentration
(0.045–0.74 mU/ml). For the final experiment, explants
exposed to 50 U/ml pronase for 3 h were cultured in the
presence of 25, 100 or 400 µg/ml of Cosamin® DS (CDS),
a mixture of glcN HCl (FCHG49®), CS (TRH 122®) and
manganese ascorbate (500, 400 and 76 mg/g, respec-
tively; Nutramax Laboratories®, Edgewood, MD), for 24 h.
The second study tested the effect of adding 100 µg/ml
CDS to tissues exposed to varying doses of stromelysin for
2 h. For comparison purposes, we also observed the effect
of 3 h of exposure to 0.25 U/ml chondroitin ABC lyase (EC
4.2.2.4) or 10 U/ml hyaluronidase (EC 3.2.1.35) (Sigma–
Aldrich, St. Louis, MO). All the tissues were pulse-labeled
during the final 4 h with 5 µCi/ml 35-sulfate. In these
studies, we monitored newly synthesized proteoglycans
incorporated into the explants or pericellular matrix of
monolayers. Hence, tissues (explants or monolayers) were
thoroughly rinsed 5X with cold DMEM and twice with cold
95% ethanol to remove unincorporated radioisotope and
labeled proteoglycan in media. Tissue were kept at 5°C in
100% ethanol overnight and were then lyophilized. Dry
weights to the nearest microgram were obtained using a
microbalance. Radiolabel uptake was determined by dis-
solving individual explants in 50 µl of 1 N NaOH at 40°C
for 1 hour, addition of 200 µl of Optiphase SuperMix scin-
tillation fluid and counting in a MicroBeta Trilux plate
counter (Perkin–Elmer–Wallac Inc., Gaithersburg, MD).
Statistical analysis of the differences between groups was
accomplished using the Student t-test and Kruskal–Wallis
nonparametric ANOVA.
STRESS INDUCTION BY HEAT STRESS
Chondrocyte monolayers conditioned to a metabolic
steady state were cultured in the presence of DMEM/F-12
containing 12% fetal calf serum at 37 and 41°C for 2 and
17 h. At the end of the stress interval, the media was
changed to DMEM/F-12+0.5% fetal calf serum containing
30 µg/ml glcN or 25 µg/ml CS or 12.4 ng/ml IGF-1, and the
cultures were placed at 37°C for 18 h to allow for recovery.
Pulse labeling with 5 µCi/ml 35-sulfate was done in the
terminal 4 h of the recovery phase and label uptake
assayed as previously described.
CYTOKINE STRESS
Chondrocyte monolayers prepared from aged joints and
conditioned to a metabolic steady state in DMEM/F-
12+12% fetal calf serum, were prelabeled with 35-sulfate
for 72 h. Unincorporated isotope was washed out by re-
peated washings and incubating for 48 h with daily media
changes. Control cultures containing plain DMEM/F-12
were compared with the cultures, to which a mixture of IL-1
beta (10 ng/ml) and plasminogen (0.35 µM) was added with
and without 25 µg/ml CS. Release radioactivity was moni-
tored daily for 72 h and the data expressed as a percentage
of the total radioactivity incorporated.
STRESS INDUCTION BY MECHANICAL COMPRESSION
Explants were preconditioned by exposure to 250 µg/ml
CDS for 10 days. A specially constructed MTS-driven
device was used to expose multiple explants to a physio-
logical level of unconfined static compression of 0.5 MPa
for 24 h at 37°C. Explants were pulse-labeled with 35-
sulfate as previously described. Individual explants were
digested with 0.4% pronase at 60°C. and aliquots were
used for: (a) assay of total glycosaminoglycan (GAG) by
the DMB reaction22, (b) isotope uptake and (c) chondroitin
4:6 sulfate ratios assessed after ABC lyase digestion and
HPLC analysis of disaccharides23. The data were ex-
pressed as 4:6 ratio, specific activity GAG (cpm/µg GAG)
and percent change from unpressurized controls.
STATISTICAL ANALYSIS
The mean, standard deviation and standard error of the
mean (S.E.M.) were evaluated for each sample group.
Means were compared using ANOVA and Student’s t-test
using the Bonferroni criteria for multiple group compari-
sons. An unpaired two-tailed Student’s t-test was employed
to test the percentage differences for statistical signifi-
cance. Significance was accepted at P<0.05.
Results
Exposure of cartilage explants to pronase induces a time
and dose-dependent upregulation of proteoglycan synthe-
sis (Fig. 1). In tissue from aged animals, maximum stimu-
lation in any single experiment occurred at 1 h using 50 U
of enzyme (+660%), but the most consistent data over
multiple experiments were obtained using 50 U for 3 h. All
the subsequent experiments were done with this dose and
time of exposure. Tissue from young animals was less
responsive and required higher amounts of enzyme or
longer digestion times to elicit an effect. Figure 2 demon-
strates the degree of depletion of Safranin-O staining
material obtained with 50 U and during the three tested
time periods using tissue from aged animals.
The metabolic response to pronase, stromelysin, hy-
aluronidase and chondroitin ABC lyase varied significantly.
While pronase significantly up regulated synthetic activity,
ABC lyase and hyaluronidase had an inhibitory effect (−34
and −37%) (Table I). Addition of 100 µg/ml CDS after
enzyme exposure did not reverse or enhance the inhibitory
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effect of ABC lyase or hyaluronidase. Interestingly, ABC
lyase with pronase reduced the pronase stimulation. How-
ever, subsequent exposure to CDS increased the synthetic
rate 34% above the CDS control and 60% above the
pronase+ABC lyase rate (Table I). The response of
pronase-treated cartilage explants from aged joints to CDS
was dose-dependent with a maximum increase in synthe-
sis of 183% obtained with 400 µg/ml (Fig. 3). At the low
CDS dose of 25 µg/ml, no effect was noted. As previously
noted, for the time interval studied, treatment of unstressed
Fig. 1. Effect of dose and time of pronase exposure on 35-sulfate incorporation into explants of cartilage obtained from young and aged
animals. (A, B, C) Explants exposed to pronase for 1, 2 and 3 h, respectively. Arrows indicate those specimens, which did not differ
significantly from control values. Data expressed as percent change from control values and represent mean±S.E.M. for six to eight replicates.
Fig. 2. Safranin-O-stained histologic sections of cartilage explants. (A) Control tissue; (B, C, D) explants exposed to 50 U pronase for 1, 2
and 3 h, respectively.
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explants with high levels of CDS usually resulted in no
change or inhibition of 35-sulfate uptake. Significant in-
creases in synthetic activity were associated with lower
doses (25 µg/ml=27–34%). Enzyme-treated tissue was
also more responsive to IGF-1 (232 vs 22%). In contrast to
pronase-induced upregulation, stromelysin gave a dose-
dependent inhibition of synthetic activity (Table II). Under
these conditions, exposure to 100 µg/ml CDS reversed this
inhibition at all but the highest enzyme dose, producing
approximately 40% stimulation.
The response of monolayer cultures of cells from aged
joints to a heat stress of 41°C for 2 or 17 h is presented in
Fig. 4. In control cultures, heat stress of 2 or 17 h induced
a maximum 23% inhibition of 35-sulfate uptake in the
recovery phase. However, response to IGF-1 increased
from 145% at 37°C to 250 and 361% at 41°C at 2 and 17 h,
respectively (Fig. 4). No response to glcN was seen at
37°C and for 2 h at 41°C, but a significant increase
(+110%) occurred after 17 h at 41°C. Similarly, CS elicited
an increased response (+70%), but only after 17 h at
41°C.
Preliminary studies in our laboratory and published data
show little evidence of an anticatabolic effect of glcN.
However, an analysis of CS activity on labeled cartilage
exposed to IL-1+plasminogen indicates a 24 h lag phase
before a reduction in catabolism is seen (Fig. 5). CS
restored metabolism to normal by 48 h.
Application of a physiological level of static compressive
stress to tissues from young animals inhibited GAG synthe-
sis by 65% (Fig. 6). Preconditioning explants by exposure
to a high level of CDS did not alter this response. However,
synthetic activity in explants from aged animals subjected
to compressive stress was stimulated by 40% over non-
stressed tissue, which was further increased to 1000%
after preconditioning with CDS. CDS conditioning also
raised the CS 4:6 ratios in aged tissue by 34% (from 0.50 to
0.67) (P<0.05).
Discussion
Adverse tissue culture conditions can be used to stimu-
late cellular stress responses of chondrocytes. Easily ap-
plicable are mechanical, chemical and temperature
stresses. The rationale for choosing the various simulations
is based on literature indicating that each may play a
significant role in cartilage biology. For example, enzyme-
stressed tissue mimics an early stage of OA associated
Fig. 3. Effect of CDS on incorporation of 35-sulfate by cartilage explants exposed to 50 U pronase for 3 h. Values representing four to six
replicates are graphed as the percent change (±S.E.M.) from control explants cultured in DMEM/F-12 without enzyme treatment. All enzyme
treatments significantly differed from control (no additions). Of the samples not exposed to enzyme, only 25 CDS was significantly higher
(+27%) than control.
Table I
35-Sulfate uptake by cartilage explants from aged animals following enzyme digestion: post-treatment response to CDS
Enzyme −CDS % P-value +CDS % P-value
Control 1425 (106) – – 1470 (90) – –
Pronase (50 U) 2640 (120) +85 0.001 – – –
ABC lyase (0.25 U/ml) 905 (42) −37 0.001 900 (70) −39 0.001
Pronase+ABC lyase 1273 (70) −11 n.s. 1965 (200) +34 0.03
Hyaluronidase (10 U/ml) 935 (94) −34 0.005 934 (60) −36 0.001
Data presented as mean±S.E.M. of cpm/mg dry tissue weight (N8). P values based on comparison with appropriate control (−CDS and
+CDS).
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with depletion of Safranin-O staining material and hyper-
metabolism of chondrocytes8. In similar studies, trypsin-
induced matrix depletion of bovine cartilage stimulated
proteoglycan synthesis at low levels of trypsin (5 µg/ml) but
inhibited proteoglycan synthesis at high levels (20 µg/ml)24.
These data are consistent with other reports using papain
or trypsin25,26.
In none of the cases cited was there any evidence that
the response of chondrocytes to matrix depletion was of
sufficient magnitude to enhance cartilage regeneration.
When used as a stimulant in vivo, exposure of chondral
lesions in rabbits to trypsin alone did not result in hyaline
cartilage regeneration27, but in the presence of blood did
affect repair. Our data indicate that glcN and CS substan-
tially enhance the proteoglycan synthetic response of
chondrocytes under in vitro conditions, simulating matrix
depletion.
In the enzyme stress studies, unstressed tissue re-
sponded maximally to low levels of glcN plus CS, higher
levels having no effect. In previous studies, we found that
high levels of CS alone can, at times, inhibit synthetic
activity in cartilage explants or monolayers. Similar results
were found by Collier and Ghosh28 and Verbruggen et al.29.
The mechanism for this biphasic dose response is un-
known, but there are several possibilities. CS may act as a
hormetic substance, low levels being protective and high
levels toxic30. Alternatively, CS activity could be regulated
by receptor-binding phenomena where stressed tissue al-
lows for higher levels of agents to be biologically effective
as a result of alterations in membrane conformation or
accessibility to membrane receptors. If surface receptors
are a requirement for CS action, normal tissue may reach
saturation of surface receptors so that elevated levels of
CS have no intracellular effect, but may exert an influence
on permeability by virtue of surface binding. High doses of
glcN, exceeding 2500 µg/ml, have also been found to be
toxic to chondrocytes, but these are considered to be
pharmacological levels and are not seen with oral dosing31.
Stromelysin (MMP-3) is considered to be one of the
major proteoglycan-degrading enzymes in cartilage32. It
has a broad range of substrate specificity, and multiple
inflammatory stimuli induce its expression in cartilage33,34.
Table II
CDS reversal of stromelysin-induced inhibition of 35-sulfate incorporation into cartilage explants obtained from aged animals
Treatments 35-Sulfate uptake (cpm/mg, S.E.M.) % Change P-value
Stromelysin (mU) CDS (µg/ml)
Control – 1720 (178) – –
0.74 – 1065 (72) −38 –
0.74 100 1155 (58) −33 n.s.
0.37 – 1365 (66) −21 –
0.37 100 1865 (60) +9 P<0.002
0.184 – 1110 (105) −35 –
0.184 100 1535 (220) −11 P<0.05
0.045 – 1405 (40) −12 –
0.045 100 1850 (30) +8 P<0.004
Data presented as mean±S.E.M. of six replicates. The % change refers to the difference between the control (without enzyme or CDS) and
samples. Significance evaluated on samples with and without CDS.
Fig. 4. Response of chondrocyte monolayers to glcN, CS and IGF-1 following heat stress. Data represent mean ±S.E.M. of six to eight
replicates. All IGF-1 values and 17 h at 41°C values are significantly different at P<0.001.
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Since the units of enzyme activity are not equilivent on the
basis of activity, it is difficult to compare their dose–
response profile (12.5 U pronase was stimulatory while
0.74 mU stromelysin was inhibitory). The loss of Safranin-O
staining after stromelysin exposure was minimal compared
with that of pronase (not shown). Even at this low dose,
which may be more physiological, the inhibition of synthetic
activity was reversed by CDS, suggesting that the net effect
of CDS exposure favored synthetic activity.
Our report on the stress response to static compression
is considered to be preliminary since the data were derived
from a single experiment. Anabolic activity in cartilage from
aged animals was elevated in response to static pressure,
whereas cartilage from young animals was depressed.
Fig. 6. Effect of preconditioning cartilage from young and aged bovine joints with glcN plus CS on metabolic response to static pressure. Data
expressed as percent change (±S.E.M.) in specific activity of GAG (cpm/µg GAG) of 10 replicates. Young tissue inhibited by −65% with no
change after CDS conditioning. Aged tissue uptake stimulated by 40% without conditioning and 1000% after conditioning.
Fig. 5. Anticatabolic effect of CS on IL-1/plasminogen-stimulated cultures of chondrocyte monolayers. Data from eight replicates expressed
as percent of total counts incorporated (±S.E.M.), which were released. Numbers reflect the total amount of radioisotope (cpm/mg dry tissue
weight) in the explants at the start of the study. Arrows indicate those values, which are significantly different at P<0.05.
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Conditioning the tissue with CDS enhanced the aged tissue
synthetic response to a level 1000% greater than non-
conditioned tissue. Similar effects were noted by Nerucci
et al.35 with mechanical and cytokine (IL-1) stresses, and
both studies confirm that stressed tissue is more respon-
sive to CS. A recent study also found that glcN could
reverse the decrease in proteoglycan synthesis elicited by
static compression36. Using 0.5 MPa for 24 h on tissues
from immature animals, Guilak et al. also got 60% inhibition
of proteoglycan synthesis using similar conditions37. Based
on our data, the inhibition of synthesis by static stress
obtained by these authors was probably due to culturing of
tissue obtained from young animals.
The cytokine stress culture system was adapted from
that described by Oleksyszyn et al.38. This system differed
from usual procedures in that it required a 72-h period of
isotope exposure providing more uniform labeling of pro-
teoglycans and exposure to IL-1 plus plasminogen to effect
greater catabolic activity. Using bovine cartilage, the cata-
bolic effect of the cytokines disappears by 72 h in spite
of daily media changes, but the data did allowed us
to observe that CS restored proteoglycan breakdown to
normal levels by 48 h.
The use of adverse conditions on chondrocytes to stimu-
late a cellular stress response was also reported by Benton
et al.39. This author found an increase in protein synthesis
by equine chondrocytes exposed to 42°C. The response
was thought to be a component of cellular protective
mechanisms. Mitrovic et al.7 studied the effect of hyperther-
mia on chondrocyte metabolism and observed decreased
synthesis of proteoglycans at temperatures above 38°C, a
loss of metachromasia in cartilage, and increased cata-
bolism of matrix macromolecules. Our observations also
suggest that increases in incubation temperature are inhibi-
tory, but uniquely demonstrate that when reequilibrated to
37°C, the chondrocyte has increased sensitivity to growth
factors like IGF-1 and the S/DMOADs glcN and CS. This
increase sensitivity resembles an overshoot phenomenon
and is substantially greater than could be accounted for by
simple recovery from the temperature-induced inhibition.
There are significant differences in the response of young
vs aged cartilage to glcN and CS, in both unstressed and
stressed environments. Tissues taken from young animals
are generally refractory to metabolic changes elicited by glcN
and CS and appear to resist responding to stress-induced
perturbations. The differences observed may be a function of
matrix mechanical properties between tissues and/or cell
sensitivity to external factors. In view of the data presented, it
is a reasonable speculation that a therapeutic regimen of
glcN, CS and manganese ascorbate may have significant
protective effects in aged joints exposed to transient or
chronic stress. In fact, a recent study demonstrates that
cartilage from osteoarthritic joints is more responsive to
polysulfated GAG than tissue from normal joints40.
In summary, glcN and CS are considered to be ‘chondro-
protective’ agents, more recently classified as S/DMOADs,
based on their activity in diminishing symptoms of OA and
retarding progression of cartilage lesions. Their ability to
modify (enhance) the response of chondrocytes to various
stresses allows them to be included in the general class of
BRM. Hence, a new therapeutic approach to OA may be
termed ‘stress resistance engineering’, which encom-
passes the use of S/DMOADs as BRMs41. This approach
aims to increase the natural stress responses of tissues,
which may contribute to increased cell survival, retardation
of progression of cartilage lesions and possibly regener-
ation of cartilage matrix.
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